Atebimetinib
Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name Atebimetinib
Trade Name
Synonyms IMM 1-104|IMM1-104|IMM-1-104
Drug Descriptions

Atebimetinib allosterically inhibits MEK1 and MEK2, potentially resulting in decreased downstream Erk1/2 activation and inhibition of tumor growth (PMID: 42478961).

DrugClasses MEK inhibitor (Pan) 27 MEK1 Inhibitor 28 MEK2 Inhibitor 26
CAS Registry Number 2669009-92-9
NCIT ID C192810

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Atebimetinib Atebimetinib 2 1
Atebimetinib + Dabrafenib Atebimetinib Dabrafenib 0 1
Atebimetinib + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin Atebimetinib Fluorouracil Irinotecan Leucovorin Oxaliplatin 0 1
Atebimetinib + Gemcitabine + Nab-paclitaxel Atebimetinib Gemcitabine Nab-paclitaxel 0 2
Atebimetinib + Pembrolizumab Atebimetinib Pembrolizumab 0 1


Additional content available in Icon for CKB-BoostCKB BOOST